Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / ISIN
-
Number of holders
-
195
-
Total shares
-
72M
-
Shares change
-
+10.6M
-
Total reported value, excl. options
-
$803M
-
Value change
-
+$124M
-
Put/Call ratio
-
0.44
-
Number of buys
-
128
-
Number of sells
-
-66
-
Price
-
$11.15
Significant Holders of SORRENTO THERAPEUTICS INC - ISIN (SRNE) as of Q3 2020
214 filings reported holding SRNE - SORRENTO THERAPEUTICS INC - ISIN as of Q3 2020.
SORRENTO THERAPEUTICS INC - ISIN (SRNE) has 195 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 72M shares
.
Largest 10 shareholders include BlackRock Inc. (15M shares), STATE STREET CORP (11.7M shares), VANGUARD GROUP INC (11.1M shares), Cormorant Asset Management, LP (6M shares), GEODE CAPITAL MANAGEMENT, LLC (3.13M shares), MORGAN STANLEY (2.74M shares), NORTHERN TRUST CORP (2.66M shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (1.37M shares), Nuveen Asset Management, LLC (1.22M shares), and GOLDMAN SACHS GROUP INC (1.17M shares).
This table shows the top 195 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.